Form 4: Jazz Pharmaceuticals President & COO Renee D Gala Sells Shares to Cover Tax Obligations
SEC Form 4
Renee D Gala, President & COO of Jazz Pharmaceuticals, sold 5,704 ordinary shares on March 5, 2025, to cover tax obligations arising from the vesting of restricted stock units.
Summary
- On March 5, 2025, Renee D Gala, the President & COO of Jazz Pharmaceuticals, sold 5,704 ordinary shares of the company.
- The shares were sold at a price of $138.95 per share.
- The sale was executed to satisfy tax obligations related to the vesting of previously granted restricted stock units.
- Following the transaction, Gala directly owns 88,895 ordinary shares of Jazz Pharmaceuticals.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover tax obligations). It's neither particularly positive nor negative.
Industry Context
Sales of shares to cover tax obligations are a routine part of executive compensation, particularly when dealing with equity-based compensation.
Stakeholder Impact
- The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.
Key Dates
| Date | Description |
|---|---|
| 03/05/2025 | Date of transaction: Renee D Gala sold 5,704 ordinary shares. |
| 03/07/2025 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.